| Literature DB >> 23966855 |
Sadri Znaidi1, Audrey Nesseir, Murielle Chauvel, Tristan Rossignol, Christophe d'Enfert.
Abstract
Sfl1p and Sfl2p are two homologous heat shock factor-type transcriptional regulators that antagonistically control morphogenesis in Candida albicans, while being required for full pathogenesis and virulence. To understand how Sfl1p and Sfl2p exert their function, we combined genome-wide location and expression analyses to reveal their transcriptional targets in vivo together with the associated changes of the C. albicans transcriptome. We show that Sfl1p and Sfl2p bind to the promoter of at least 113 common targets through divergent binding motifs and modulate directly the expression of key transcriptional regulators of C. albicans morphogenesis and/or virulence. Surprisingly, we found that Sfl2p additionally binds to the promoter of 75 specific targets, including a high proportion of hyphal-specific genes (HSGs; HWP1, HYR1, ECE1, others), revealing a direct link between Sfl2p and hyphal development. Data mining pointed to a regulatory network in which Sfl1p and Sfl2p act as both transcriptional activators and repressors. Sfl1p directly represses the expression of positive regulators of hyphal growth (BRG1, UME6, TEC1, SFL2), while upregulating both yeast form-associated genes (RME1, RHD1, YWP1) and repressors of morphogenesis (SSN6, NRG1). On the other hand, Sfl2p directly upregulates HSGs and activators of hyphal growth (UME6, TEC1), while downregulating yeast form-associated genes and repressors of morphogenesis (NRG1, RFG1, SFL1). Using genetic interaction analyses, we provide further evidences that Sfl1p and Sfl2p antagonistically control C. albicans morphogenesis through direct modulation of the expression of important regulators of hyphal growth. Bioinformatic analyses suggest that binding of Sfl1p and Sfl2p to their targets occurs with the co-binding of Efg1p and/or Ndt80p. We show, indeed, that Sfl1p and Sfl2p targets are bound by Efg1p and that both Sfl1p and Sfl2p associate in vivo with Efg1p. Taken together, our data suggest that Sfl1p and Sfl2p act as central "switch on/off" proteins to coordinate the regulation of C. albicans morphogenesis.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23966855 PMCID: PMC3744398 DOI: 10.1371/journal.ppat.1003519
Source DB: PubMed Journal: PLoS Pathog ISSN: 1553-7366 Impact factor: 6.823
Strains used in this study.
| Strain name | Lab identifier | Parental strain | Relevant genotype | Reference |
| SC5314 | CEC1462 | Prototrophic |
| |
| CAI4 | CEC2095 | SC5314 |
|
|
| BWP17H | CEC157 | BWP17 |
| Lab collection |
| BWP17AH | CEC161 | BWP17 |
|
|
| SN76 | CEC805 |
|
| |
| HLC52 | CEC150 |
|
| |
| HLCEEFG1 | CEC3891 | CAI4 |
|
|
| AVL12 | CEC3894 | BWP17 |
|
|
| AVL12-SFL1-TAP | CEC3923 | AVL12 |
| This study |
| AVL12-SFL2-TAP | CEC3916 | AVL12 |
| This study |
| AVL12-pHIS | CEC3913 | AVL12 |
| This study |
| SGY243-CaEXP-B | CEC2894 | SGY243 |
|
|
| SGY243-CaEXP-CAP1-HA | CEC2895 | SGY243 |
|
|
| CEC1561 | CEC1561 | SN76 |
| This study |
| SFL1-TAP | CEC1922 | CEC1561 |
| This study |
| CEC1422 | CEC1422 | SN76 |
| This study |
| SFL2-TAP | CEC1918 | CEC1422 |
| This study |
| CEC3075 | CEC3075 | CEC1561 |
| This study |
| CEC3076 | CEC3076 | CEC1422 |
| This study |
|
| CEC1910 | CEC1561 |
| This study |
| CEC1997 | CEC1997 | CEC1910 |
| This study |
|
| CEC3283 | CEC1910 |
| This study |
|
| CEC3284 | CEC1910 |
| This study |
|
| CEC1503 | CEC1422 |
| This study |
|
| CEC3253 | CEC1503 |
| This study |
|
| CEC3254 | CEC1503 |
| This study |
|
| CEC2001 | CEC1910 |
| This study |
|
| CEC2658 | CEC1910 |
| This study |
|
| CEC1535 | CEC1503 |
| This study |
| CEC1509 | CEC1509 | CEC1503 |
| This study |
|
| CEC2840 | CEC1910 |
| This study |
|
| CEC2009 | SN76 |
| This study |
|
| CEC2058 | CEC2009 |
| This study |
| CEC3485 | CEC3485 | BWP17AH |
| This study |
| CEC2988 | CEC2988 | BWP17AH |
| This study |
| CEC3431 | CEC3431 | CEC1910 |
| This study |
| CEC3484 | CEC3484 | CEC1910 |
| This study |
| CEC3435 | CEC3435 | CEC1503 |
| This study |
| CEC3437 | CEC3437 | CEC1503 |
| This study |
|
| CEC2656 | SN76 |
| This study |
| CEC3583 | CEC3583 | CEC2656 |
| This study |
| CEC3585 | CEC3585 | CEC2656 |
| This study |
|
| CEC2335 | SN76 |
| This study |
| CEC3589 | CEC3589 | CEC2335 |
| This study |
| CEC3591 | CEC3591 | CEC2335 |
| This study |
| CEC3581 | CEC3581 | CEC2009 |
| This study |
| CEC3642 | CEC3642 | CEC2009 |
| This study |
|
| CEC1439 | HLC52 |
| This study |
| CEC3581 | CEC3581 | CEC1439 |
| This study |
| CEC3156 | CEC3156 | CEC1439 |
| This study |
Figure 1Strategy for tagging Sfl1p and Sfl2p with a triple hemagglutinin (3×HA) epitope tag and characterization of the tagged strains.
(A) Schematic representation of the SFL1-HA or SFL2-HA tagging cassette allowing expression of the Sfl1p-HA3 or Sfl2p-HA3 fusion proteins following a StuI digestion (StuI) and integration at the RPS1 locus (RPS1, black rectangles) [42]. A triple HA tag (dark grey box) was inserted in frame with the SFL1 or SFL2 coding sequences (SFL1 or SFL2; black arrowed rectangle) in plasmid pCaEXP [42]. The tagged alleles are placed under the control of the MET3 promoter (MET3p; ligh grey rectangle), which is induced in the absence of methionine and cysteine, and are followed by the C. albicans URA3 marker (open rectangle). (B) Western blot analysis of homozygous sfl1 or sfl2 mutants (sfl1Δ/sfl1Δ or sfl2Δ/sfl2Δ) expressing HA3-tagged versions of the SFL1 or SFL2 genes, respectively (SFL1-HA or SFL2- HA) together with the corresponding empty vector controls (Vector). The SGY243 strain expressing the CAP1-HA (CAP1-HA) or carrying the empty vector (Vector) were used as a positive control [43]. Strains were grown overnight in SD medium (P-inducing conditions) and total protein extracts were prepared then subjected to SDS-PAGE. Western blotting was performed using an anti-HA antibody. Positions of the molecular mass standards are indicated on the left (kDa). Immunopositive signals from the Sfl1p-HA3 and Sfl2p-HA3 fusions are indicated with black arrows (C) Phenotypic analysis of the strains expressing the HA3-tagged SFL1 or SFL2 alleles. Strain SC5314 (control) together with the homozygous sfl1 or sfl2 mutants expressing the SFL1-HA or SFL2-HA alleles (SFL1-HA, SFL2-HA), respectively, or carrying the empty vector (Vector) were grown overnight in YPD at 30°C then transferred to Lee's medium lacking methionine and cysteine and allowed to grow during 4 h at 37°C before being examined microscopically (40× magnification).
Figure 2Genome-wide location of Candida albicans Sfl1p and Sfl2p, in vivo, at a single-nucleotide resolution.
(A) Venn diagram of the overlap between Sfl1p and Sfl2p binding targets. All 113 Sfl1p targets are also bound by Sfl2p, while 75 target promoters are Sfl2p-specific. The total number of Sfl1p or Sfl2p target promoters are indicated between parentheses. Target promoters include those that are clearly associated with given ORFs as well as those that are shared by two ORFs in opposite orientations. (B) A single-nucleotide resolution of Sfl1p and Sfl2p binding at selected C. albicans genomic regions in vivo. Plotted are read-count signal intensities of HA3-tagged SFL1- (sfl1-CaEXP-SFL1-HA) or SFL2- (sfl2-CaEXP-SFL2-HA) coimmunoprecipitated DNA and the corresponding empty-vector control signals (sfl1-CaEXP, sfl2-CaEXP, respectively) from merged BAM files of two independent biological replicates. Some read-count signals extend beyond the maximum graduation (not shown) that ranges between 0–500 reads for Sfl1 data (sfl1-CaEXP and sfl1-CaEXP-SFL1-HA) and 0–1000 reads for Sfl2 data (sfl2-CaEXP and sfl2-CaEXP-SFL2-HA). The position of each signal in selected C. albicans genomic regions from assembly 21 is shown on the x-axis. The location of each selected region from the corresponding chromosome (Chr) is indicated at the top of each panel (limits are shown between parentheses in base pairs). The orientation of each ORF is depicted by the arrowed black rectangle. (C) Enrichment scores of the Gene Ontology (GO) terms to which are assigned Sfl1p and Sfl2p common (shaded area) or Sfl2p-specific (unshaded area) binding targets. GO term enrichment scores are calculated as the negative value of the log10-transformed P-value. The number of genes of each category is shown at the right of each horizontal bar.
Overrepresented functional categories in Sfl1p and Sfl2p ChIP-Seq data.
| GO term | CGD accession # (ontology classification) | % Frequency | % Genome frequency |
| Genes |
|
| |||||
| Sequence-specific DNA binding transcription factor activity | GO:0003700 | 19.1 (21) | 3.5 (230) | 0.0000 |
|
| Filamentous growth | GO:0030447 | 27.3 (30) | 8.4 (550) | 0.0000 |
|
| Regulation of transcription, DNA-dependent | GO:0006355 | 26.4 (29) | 9.2 (601) | 0.0001 |
|
| Response to stimulus | GO:0050896 | 40.9 (45) | 19.8 (1290) | 0.0001 |
|
| Pathogenesis | GO:0009405 | 14.5 (16) | 3.3 (215) | 0.0002 |
|
| Biofilm formation | GO:0042710 | 10.9 (12) | 2.0 (128) | 0.0006 |
|
| Galactose catabolic process via UDP-galactose | GO:0033499 | 2.7 (3) | 0.0 (3) | 0.0022 |
|
| Cellular response to drug | GO:0035690 | 15.5 (17) | 4.4 (287) | 0.0025 |
|
| Cellular response to nutrient levels | GO:0031669 | 16.4 (18) | 5.0 (323) | 0.0030 |
|
| Cellular response to pH | GO:0071467 | 8.2 (9) | 1.2 (81) | 0.0036 |
|
| Regulation of flocculation | GO:0060256 | 3.6 (4) | 0.2 (10) | 0.0071 |
|
| Regulation of phenotypic switching | GO:1900239 | 3.6 (4) | 0.2 (15) | 0.0434 |
|
|
| |||||
| Fungal-type cell wall | GO:0009277 | 15.1 (11) | 2.2 (142) | 0.0000 |
|
| Multi-organism process | GO:0051704 | 26.0 (19) | 6.4 (418) | 0.0000 |
|
| Symbiosis, encompassing mutualism through parasitism | GO:0044403 | 12.3 (9) | 1.9 (126) | 0.0022 |
|
| Biofilm formation | GO:0042710 | 12.3 (9) | 2.0 (128) | 0.0025 |
|
| Sequence-specific DNA binding transcription factor activity | GO:0003700 | 15.1 (11) | 3.5 (230) | 0.0027 |
|
| Adhesion to host | GO:0044406 | 8.2 (6) | 0.7 (47) | 0.0027 |
|
Grouping of the Sfl1p and/or Sfl2p targets identified in ChIP-Seq data according to GO terminology determined by using the online CGD GO Term Finder tool (http://www.candidagenome.org/cgi-bin/GO/goTermFinder). Analysis conducted in October 2012 (See Materials and Methods).
Ontology classification according to the three GO terminologies (biological process, cellular component and molecular function).
Percentages were calculated based on the number of genes in each GO category divided by the total number (110 genes for Sfl1p and Sfl2p common targets, 73 genes for Sfl2p specific targets, see Materials and Methods for details).
Percentages were calculated based on the number of genes in each category divided by the total number of annotated genes of the C. albicans genome, according to CGD (6,513 genes).
P values for the overrepresented categories were calculated using a hypergeometric distribution with multiple hypothesis correction (i.e., Bonferroni's correction) as described in the GO Term Finder tool website (http://www.candidagenome.org/help/goTermFinder.shtml). The P value cutoff used was ≤0.05.
Gene name or orf19 nomenclature according to CGD. Some genes were attributed to more than one GO term.
Figure 3Binding of Sfl1p-HA3 and Sfl2p-HA3 to selected target promoters.
Strains sfl1-CaEXP-SFL1-HA (Sfl1p-HA3) and sfl2-CaEXP-SFL2-HA (Sfl2p-HA3) together with their respective untagged control strains (Vector) were grown under the same conditions as those for the ChIP-Seq experiment prior to ChIP followed by PCR to detect specific Sfl1p and Sfl2p binding enrichment at selected target promoters (See Materials and Methods for details). PCR was performed using primers corresponding to the promoter region of the indicated genes. The URA3 and YAK1 genes were used as a negative control for ChIP enrichment. Primer efficiency (shown on the right panel) was tested by the ability of the corresponding primers to quantify 10-fold serially diluted whole cell extract DNA (WCE, ChIP input samples, dilution factors are indicated at the top of the right panel).
Figure 4Sfl1p and Sfl2p transcriptomics.
(A) GeneSpring expression profile plots of each of the three biological replicates from the sfl1-CaEXP-SFL1-HA versus sfl1-CaEXP (sfl1-CaEXP-SFL1-HA vs. sfl1-CaEXP) and the sfl2-CaEXP-SFL2-HA versus sfl2-CaEXP (sfl2-CaEXP-SFL2-HA vs. sfl2-CaEXP) transcriptomics data. The log2-transformed relative expression level of each gene from averaged signal intensities of two nonoverlapping gene-specific microarray probes (See Materials and Methods for details), is shown on the y-axis and the corresponding biological replicate sample for each condition (1, 2 and 3) is shown on the x-axis. The profile plot is coloured according to the ratio observed for replicate 1 in the sfl1-CaEXP-SFL1-HA vs. sfl1-CaEXP condition. (B) Heat maps of the 30 highest log2-transformed relative gene expression levels in the sfl1-CaEXP-SFL1-HA versus sfl1-CaEXP (sfl1-CaEXP-SFL1-HA vs sfl1-CaEXP, left panels, UP and DWN) and the sfl2-CaEXP-SFL2-HA versus sfl2-CaEXP (sfl2-CaEXP-SFL2-HA vs sfl2-CaEXP, right panels, UP and DWN) transcriptomics data (combination of the 3 biological replicates in each condition). The most upregulated (UP, descending signal intensity) or downregulated (DWN, ascending signal intensity) genes in sfl1-CaEXP-SFL1-HA vs. sfl1-CaEXP (left panels, SFL1 column) or sfl2-CaEXP-SFL2-HA vs. sfl2-CaEXP (SFL2, right panels) transcriptomics data and their matching probe intensities from the sfl2-CaEXP-SFL2-HA vs. sfl2-CaEXP condition (left panels, SFL2 column) or the sfl1-CaEXP-SFL1-HA vs. sfl1-CaEXP (right panels, SFL1 column), respectively, are indicated with their corresponding name or orf19 nomenclature. Heat maps were constructed using Genesis version 1.7.6 [83].
Figure 5Quantitative real-time RT-PCR analysis of selected genes from SFL1 and SFL2 transcriptomics data.
(A) Expression of the SFL1, SFL2 and BRG1 genes was quantified by qRT-PCR experiments in SFL1-deficient strains carrying or not a functional SFL1-TAP fusion [41] and grown during 0, 2 and 4 hours under gluconeogenic conditions (CEC2001 and CEC1997, respectively, Table 1). Expression of the SFL2 and BRG1 genes is repressed upon SFL1 expression. Logarithmic scales are shown in each panel. (B) Expression of the SFL2, SFL1, UME6 and ALS3 genes was quantified by qRT-PCR experiments in an SFL2-deficient strain carrying or not a functional SFL2-TAP fusion [41] and grown during 0, 2 and 4 hours under gluconeogenic conditions (CEC1509 and CEC1535, respectively). Expression of the SFL1 gene is repressed at time point 2 h, whereas those of UME6 and ALS3 are induced. Logarithmic scales are shown in each panel. Bars in each graph indicate log-transformed relative changes in RNA expression of the indicated samples as compared to the CEF3 calibrator control (see Materials and Methods). Error bars denote standard deviations.
Figure 6Sfl1p and Sfl2p transcriptional modules.
Venn diagrams of the overlap between the genes that are modulated in (A) SFL1 or SFL2 transcriptomics (light red circles, upregulated; light green circles, downregulated; gene expression fold-change cut-off ≥1.5; P-value cut-off ≤0.05) and commonly bound by Sfl1p and Sfl2p (light blue circle) or (B) SFL2 transcriptomics (light red circle, upregulated; light green circle, downregulated; gene expression fold-change cut-off ≥1.5; P-value cut-off ≤0.05) and specifically bound by Sfl2p (light grey circle). Numbers in the Venn diagrams indicate the number of genes. Circled numbers indicate the number of genes that are (A) both modulated in SFL1 or SFL2 transcriptomics data and commonly bound by Sfl1p and Sfl2p or (B) both modulated in SFL2 transcriptomics data and specifically bound by Sfl2p. The name of these genes (or their orf19 nomenclature) and the functional categories to which they belong are shown in the linked boxes. *, DCK1 is required for hyphal formation; orf19.3475 is a hyphal induced gene.
Figure 7Genetic interactions of SFL1 and SFL2 with their transcriptional target genes encoding key regulators of hyphal development.
(A) The wild-type SC5314 (WT) together with the homozygous sfl1 (sfl1ΔΔ, CEC2001), sfl2 (sfl2ΔΔ,CEC1535), brg1 (brg1ΔΔ, CEC2058), the double homozygous sfl1, sfl2 (sfl1ΔΔ sfl2ΔΔ, CEC2658) and sfl1, brg1 (sfl1ΔΔ brg1ΔΔ, CEC2840) mutants were grown in yeast-promoting (SD at 30°C for 6 h30 min) or sub-hypha-inducing (YP 10% FBS at 30°C for 6 h30 min) conditions and observed microscopically. Scale bar = 10 µm. The detailed cell morphology of each strain grown in YP 10% FBS are shown (Morphological details, bottom panel) (B) The pNIMX expression system [41] was used to drive anhydrotetracycline-dependent overexpression of SFL2 (P-SFL2) in a wild-type (WT, BWP17AH complemented for uracil auxotrophy) or in different homozygous mutant backgrounds, including sfl1Δ/sfl1Δ (sfl1ΔΔ), sfl2Δ/sfl2Δ (sfl2ΔΔ), ume6Δ/ume6Δ (ume6ΔΔ), tec1Δ/tec1Δ (tec1ΔΔ), brg1Δ/brg1Δ (brg1ΔΔ) and efg1Δ/efg1Δ (efg1ΔΔ) (Table 1). All strains were grown in YPD medium at 30°C during 18 hours in the presence of 3 µg/ml of anhydrotetracycline before microscopic examination. As a control, the same growth conditions were also used with all strain backgrounds carrying the empty plasmid (CIp10, Control). Two different fields with detailed cell morphology of each strain overexpressing SFL2 are shown (Morphological details, right panels).
Figure 8Sfl1p and Sfl2p binding locations overlap with those of Ndt80p and Efg1p.
(A, B and C) Motif discovery analyses of Sfl1p and Sfl2p binding data. Motif logos of conserved sequences in (A) Sfl1p- and (B) Sfl2p-enriched DNA fragments as well as in (C) fragments overlapping with binding regions that are specific to Sfl2p. DNA sequences encompassing ±250 bp around peak summits in Sfl1p or Sfl2p binding data were used as input for motif discovery using two independent motif discovery algorithms, the RSA-tools (RSAT) peak-motifs (http://rsat.ulb.ac.be/rsat/, [55]) and SCOPE (genie.dartmouth.edu/scope/, [56]) (See Materials and Methods for details). High scoring motifs from either SCOPE or RSAT algorithms are shown. These include the Ndt80p and Efg1p binding motifs, suggesting a functional interaction between Sfl1p, Sfl2p, Ndt80p and Efg1p. The distribution of motif occurrences in the input sequences are shown at the right of each motif panel. Plotted are the number of occurrences of each motif (y-axis, motif occurrence) at a given position relative to peak center (distance to peak center in base pairs, x-axis). (D) Overlap of Ndt80p and Efg1p binding with Sfl1p and Sfl1p occupancies at selected locations from the C. albicans genome (selected genome interval shown above each panel). Genome-wide location data from Sellam et al. (Ndt80p, from 59-bp tiling array data, one of the two replicates of the study is shown [57]) and Lassak et al. (Efg1p, from 50–75-mer tiling array data for Efg1p binding in cells grown under yeast form and during hyphal induction [51], one of the three replicates in each condition is shown) are used to compare Ndt80p and Efg1p binding profiles to those of Sfl1p and Sfl2p (read counts in 10 bp windows from wiggle files of Sfl1p and Sfl2p binding data were used).
Figure 9Efg1p binds to the promoter of many Sfl1p and Sfl2p targets and co-immunoprecipitates with Sfl1p and Sfl2p, in vivo.
(A) ChIP-PCR assay of selected Sfl1p and Sfl2p target promoters. Strains SFL1-TAP (CEC1922), SFL2-TAP (CEC1918) and EFG1-HA (HLCEEFG1) were grown in SC medium at 30°C (30°C) or in Lee's medium at 37°C (37°C) together with the SC5314 control strain (Control) during 4 h before being subjected to chromatin immunoprecipitation (Anti-TAP, Anti-HA) followed by PCR using primers specific to the indicated promoter regions. The URA3 and YAK1 genes were used as negative controls for ChIP enrichment. (B) Co-Immunoprecipitation of Efg1p with Sfl1p and Sfl2p. Strains coexpressing SFL1-TAP and EFG1-HA (Lanes 2 and 3) or SFL2-TAP and EFG1-HA (Lanes 7 and 8) or controls (Lanes 1 and 6, EFG1-HA only; lanes 4 and 9, SFL1-TAP only; lanes 5 and 10, SFL2-TAP only) were cultivated in SC medium at 30°C or in Lee's medium at 37°C before crosslinking with formaldehyde. Total extracts were incubated with Dynal PanMouse IgG beads directed against TAP epitope tag prior to washing and Western blotting using anti-TAP (IP Anti-TAP, 10% of the beads/total extracts mixture) and anti-HA (Co-IP Anti-HA) antibodies. A portion of the total cell extracts (∼2%) was included to verify the presence of the Efg1p-HA fusion (Total extracts Anti-HA).
Figure 10Model of Sfl1p and Sfl2p regulatory network.
Sfl2p (red oval), which induces hyphal growth in response to temperature increase or upon overexpression (red dashed arrow), and Sfl1p (orange oval) bind directly, together with Efg1p and Ndt80p depending on growth conditions (green and white ovals, respectively; dashed lines indicate hypothetical physical and/or functional interaction), to the promoter of common (blue boxes) target genes encoding major transcriptional activators (UME6, TEC1 and BRG1) or repressors (NRG1, RFG1, SSN6) of hyphal growth as well as to the promoter of genes associated with yeast-form growth (RME1, RHD1 and YWP1) and modulate the expression of many of them (for simplicity, only modulatory direct interactions are shown i.e. both binding at and transcriptional modulation of a given target; arrowed lines indicate direct upregulation whereas blunt lines indicate direct downregulation). On the other hand, Sfl2p directly upregulates the expression of specific targets (grey boxes), including a high proportion of hyphal-specific genes (HSGs), while exerting a direct negative regulation on the expression of yeast-form associated genes (PIR1 and RHD3). Sfl1p and Sfl2p also exert a direct negative regulation on the expression of each other. The execution of Sfl1p or Sfl2p transcriptional control inputs allows to regulate the commitment (dashed line; blunt, inhibition; arrowed, activation) of C. albicans to form hyphae or yeast-form cells.